Categories for Priority News

Video presentation (ENG) of clinical status of RP101 by CEO Martin Vidaeus

December 5, 2019 3:54 pm Published by jonas

Presentation at BioStock Live

September 2, 2019 11:04 am Published by jonas

Interview CEO: Update regarding financing and Phase II trial

June 19, 2019 3:54 pm Published by jonas

Presentation during Stora Aktiedagen Stockholm 2018

November 26, 2018 9:55 pm Published by jonas

Video interview during Småbolagsdagen 2018

June 13, 2018 9:55 am Published by jonas

Video interview during Aktiedagen Lund 2018

January 30, 2018 12:00 pm Published by jonas

Analyst Group presents investment analysis of Redwood Pharma

June 13, 2017 12:00 pm Published by jonas

Redwood Pharma AB – End of Year Report 2016

February 15, 2017 12:00 pm Published by jonas

Redwood Pharma

We develop ophthalmic drugs that address major medical needs. We focus on early-stage clinical development. Our long-term strategy is to enter into licence agreements with other drug companies who will in turn introduce products for the global market.

Redwood Pharma

Vi utvecklar ögonläkemedel för stora medicinska behov. Tonvikten ligger på tidig klinisk utveckling. Den långsiktiga strategin är att teckna licensavtal med andra läkemedelsbolag, som i sin tur kan introducera produkterna på världsmarknaden.